BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 20864414)

  • 21. DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy.
    Quintela-Fandino M; Hitt R; Medina PP; Gamarra S; Manso L; Cortes-Funes H; Sanchez-Cespedes M
    J Clin Oncol; 2006 Sep; 24(26):4333-9. PubMed ID: 16896002
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Nucleotide excision repair gene polymorphisms and recurrence after treatment for superficial bladder cancer.
    Gu J; Zhao H; Dinney CP; Zhu Y; Leibovici D; Bermejo CE; Grossman HB; Wu X
    Clin Cancer Res; 2005 Feb; 11(4):1408-15. PubMed ID: 15746040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association of BER and NER pathway polymorphism haplotypes and micronucleus frequencies with global DNA methylation in benzene-exposed workers of China: Effects of DNA repair genes polymorphisms on genetic damage.
    Zhang GH; Ren JC; Luo M; Cui J; Du Y; Yang D; Cui S; Wang X; Wu W; Cao J; Xia ZL
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Mar; 839():13-20. PubMed ID: 30744808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polymorphisms of DNA repair genes XPD and XRCC1 and risk of cataract development.
    Unal M; Güven M; Batar B; Ozaydin A; Sarici A; Devranoğlu K
    Exp Eye Res; 2007 Sep; 85(3):328-34. PubMed ID: 17637462
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Regulation of DNA repair gene expression in human cancer cell lines.
    McGurk CJ; Cummings M; Köberle B; Hartley JA; Oliver RT; Masters JR
    J Cell Biochem; 2006 Apr; 97(5):1121-36. PubMed ID: 16315315
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Insulin-like growth factors II exon 9 and E-cadherin-Pml I but not myeloperoxidase promoter-463, urokinase-ApaL I nor xeroderma pigmentosum polymorphisms are associated with higher susceptibility to leiomyoma.
    Hsieh YY; Chang CC; Wang YK; Hsu KH; Chen CP; Hsu CM; Tsai FJ
    Anticancer Res; 2010 Jun; 30(6):2203-8. PubMed ID: 20651370
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD.
    Chiang CC; Tsai YY; Bau DT; Cheng YW; Tseng SH; Wang RF; Tsai FJ
    Mol Vis; 2010 Apr; 16():698-704. PubMed ID: 20431719
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer.
    Park JY; Park SH; Choi JE; Lee SY; Jeon HS; Cha SI; Kim CH; Park JH; Kam S; Park RW; Kim IS; Jung TH
    Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):993-7. PubMed ID: 12376498
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Polymorphisms of DNA repair genes and risk of non-small cell lung cancer.
    Zienolddiny S; Campa D; Lind H; Ryberg D; Skaug V; Stangeland L; Phillips DH; Canzian F; Haugen A
    Carcinogenesis; 2006 Mar; 27(3):560-7. PubMed ID: 16195237
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interindividual variation in nucleotide excision repair genes and risk of endometrial cancer.
    Weiss JM; Weiss NS; Ulrich CM; Doherty JA; Voigt LF; Chen C
    Cancer Epidemiol Biomarkers Prev; 2005 Nov; 14(11 Pt 1):2524-30. PubMed ID: 16284373
    [TBL] [Abstract][Full Text] [Related]  

  • 31. DNA repair gene polymorphisms and prostate cancer risk in South Australia--results of a pilot study.
    Dhillon VS; Yeoh E; Fenech M
    Urol Oncol; 2011; 29(6):641-6. PubMed ID: 19914098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. XPA versus ERCC1 as chemosensitising agents to cisplatin and mitomycin C in prostate cancer cells: role of ERCC1 in homologous recombination repair.
    Cummings M; Higginbottom K; McGurk CJ; Wong OG; Köberle B; Oliver RT; Masters JR
    Biochem Pharmacol; 2006 Jul; 72(2):166-75. PubMed ID: 16756962
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Polymorphisms of the DNA repair genes XPD (Lys751Gln) and XRCC1 (Arg399Gln and Arg194Trp): relationship to breast cancer risk and familial predisposition to breast cancer.
    Brewster AM; Jorgensen TJ; Ruczinski I; Huang HY; Hoffman S; Thuita L; Newschaffer C; Lunn RM; Bell D; Helzlsouer KJ
    Breast Cancer Res Treat; 2006 Jan; 95(1):73-80. PubMed ID: 16319991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms of the DNA repair genes XPD and XRCC1 and the risk of age-related macular degeneration.
    Görgün E; Güven M; Unal M; Batar B; Güven GS; Yenerel M; Tatlipinar S; Seven M; Yüksel A
    Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4732-7. PubMed ID: 20375340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis.
    Hu Z; Wei Q; Wang X; Shen H
    Lung Cancer; 2004 Oct; 46(1):1-10. PubMed ID: 15364127
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG).
    Güven M; Unal M; Batar B; Eroğlu E; Devarnoğlu K; Tamçelik N; Uçar D; Sarici A
    Mol Vis; 2007 Jan; 13():12-7. PubMed ID: 17242676
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in nucleotide excision repair capacity between newly diagnosed colorectal cancer patients and healthy controls.
    Slyskova J; Naccarati A; Pardini B; Polakova V; Vodickova L; Smerhovsky Z; Levy M; Lipska L; Liska V; Vodicka P
    Mutagenesis; 2012 Mar; 27(2):225-32. PubMed ID: 22294771
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Polymorphisms in nucleotide excision repair genes, polycyclic aromatic hydrocarbon-DNA adducts, and breast cancer risk.
    Crew KD; Gammon MD; Terry MB; Zhang FF; Zablotska LB; Agrawal M; Shen J; Long CM; Eng SM; Sagiv SK; Teitelbaum SL; Neugut AI; Santella RM
    Cancer Epidemiol Biomarkers Prev; 2007 Oct; 16(10):2033-41. PubMed ID: 17932351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combinations of polymorphisms in XPD, XPC and XPA in relation to risk of lung cancer.
    Vogel U; Overvad K; Wallin H; Tjønneland A; Nexø BA; Raaschou-Nielsen O
    Cancer Lett; 2005 May; 222(1):67-74. PubMed ID: 15837542
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA repair gene polymorphisms and genetic predisposition to cutaneous melanoma.
    Povey JE; Darakhshan F; Robertson K; Bisset Y; Mekky M; Rees J; Doherty V; Kavanagh G; Anderson N; Campbell H; MacKie RM; Melton DW
    Carcinogenesis; 2007 May; 28(5):1087-93. PubMed ID: 17210993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.